|
|
Volumn 4, Issue 1, 2014, Pages
|
|
Ibrutinib approved for mantle cell lymphoma
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BORTEZOMIB;
IBRUTINIB;
LENALIDOMIDE;
RITUXIMAB;
CANCER PROGNOSIS;
CHRONIC LYMPHATIC LEUKEMIA;
DISEASE COURSE;
HUMAN;
MANTLE CELL LYMPHOMA;
NOTE;
PHASE 2 CLINICAL TRIAL (TOPIC);
TREATMENT OUTCOME;
TREATMENT RESPONSE;
|
|
EID: 85047656093
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2013-172 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|